Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schober

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Infection and Immunity|May 22, 2019
Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T LymphocytesBrian A Vega, Liam T Schober, Tami Kim, et al.
Infection|July 16, 2025
Diverse clinical manifestations of Parvovirus B19 infections during the 2024 outbreak in GermanyA Holzem, J Stemler, S Böhm, et al.
British Journal of Cancer|January 17, 2013
Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study GroupK Behringer, H Müller, H Görgen, et al.
Nature Communications|January 24, 2017
A human immunodeficiency syndrome caused by mutations in CARMIL2T Schober, T Magg, M Laschinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trialM Sieber, H Tesch, B Pfistner, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Infection and Immunity|May 22, 2019
Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T LymphocytesBrian A Vega, Liam T Schober, Tami Kim, et al.
Infection|July 16, 2025
Diverse clinical manifestations of Parvovirus B19 infections during the 2024 outbreak in GermanyA Holzem, J Stemler, S Böhm, et al.
British Journal of Cancer|January 17, 2013
Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study GroupK Behringer, H Müller, H Görgen, et al.
Nature Communications|January 24, 2017
A human immunodeficiency syndrome caused by mutations in CARMIL2T Schober, T Magg, M Laschinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trialM Sieber, H Tesch, B Pfistner, et al.
Pageof 2